Weaver Capital Management’s CVS Health CVS Stock Holding History

Weaver Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,689	Closed	-$513K	–	178
2024 Q2	$513K	Sell	8,689 -12,380	-59%	-$774K	0.17%	111
2024 Q1	$1.68M	Buy	21,069 +4,792	+29%	+$366K	0.57%	55
2023 Q4	$1.29M	Buy	+16,277	New	+$1.16M	0.51%	61

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Weaver Capital Management's CVS Position: Q3 2024 in Review

Weaver Capital Management sold out of CVS Health (CVS) in Q3 2024, closing a stake of 8,689 shares — an estimated $513K sold.

Weaver Capital Management first reported a position in CVS in Q4 2023 and held it in 3 quarters. The position peaked at $1.68M in Q1 2024. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Weaver Capital Management reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Weaver Capital Management sold 8,689 CVS Health shares in Q3 2024, an estimated $513K.
Weaver Capital Management first reported a position in CVS Health in Q4 2023 and held it in 3 quarters.
Weaver Capital Management's CVS Health position peaked at $1.68M in Q1 2024.
1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Weaver Capital Management's 13F filing for Q3 2024, filed 22 Oct 2024.